Concord Biotech informs about board meeting

06 Nov 2024 Evaluate

Concord Biotech has informed that the meeting of the Board of Directors of the Company will be held on Monday, November 11, 2024 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Second quarter and half year ended September, 30, 2024 along with limited review report to be issued by the Statutory Auditors and to consider other business matters, if any. Further, in continuation of its earlier letter dated 25 September, 2024 under subject ‘Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relative, the trading window for dealing in the securities of the Company shall remain closed up to 48 hours after the declaration of the Financial Results of the Company for the Second quarter and half year ended September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

2127.50 -1.90 (-0.09%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.